Sort
8,912 grants matching “sars cov 2”
Pandemic Influenza Translational Research and novel universal countermeasure development
$5,343,633Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Program in Clinical Research, Clinical Support Services and Clinical Training
$5,332,395Janet Hall · National Institute Of Environmental Health Sciences · ZID · FY2023 · ES
Structural Biology and Computational Modeling Core
$5,326,632Lawrence Shapiro · Hackensack University Medical Center · U19 · FY2022 · AI
CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16
$5,323,993Lawrence Corey · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI
Virology Core
$5,289,678Charles M. Rice · Hackensack University Medical Center · U19 · FY2022 · AI
CEIRS - SARS-CoV-2 RESEARCH
$5,257,845Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2020 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit - KidCOVE
$5,245,366Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines
$5,198,360Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$5,173,553Michele K Evans · National Institute On Aging · ZIA · FY2022 · AG
Developing Antivirals Targeting Proteases and Polymerases of Coronaviruses, Picornaviruses and Bunyavirales
$5,168,269Charles Scott Craik · University Of California, San Francisco · U19 · FY2022 · AI
Functional decoding of signaling dynamics in single immune cells
$5,151,116Myong-Hee Sung · National Institute On Aging · ZIA · FY2022 · AG
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination
$5,125,237Mark Joseph Mulligan · Emory University · U19 · FY2020 · AI
Development of CoV inhibitors against non-enzymatic targets
$5,121,996Adolfo Garcia-Sastre · Scripps Research Institute, The · U19 · FY2022 · AI
Research Project 1: Coronavirus antiviral lead development and combination testing
$5,087,610Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Development and Production of SARS-CoV2 Biologicals and Vaccines
$5,062,451Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI
Center for Human Immunology
$5,049,028Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
BPCA-PTN COVID-19 STUDIES
$5,000,000Md, Kanecia Zimmerman · Duke University · N01 · FY2020 · HD
Project 5: Pandemic Virus Helicase Inhibitors
$4,951,273Donghoon Chung · University Of Minnesota · U19 · FY2022 · AI
RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM: PROJECT NO 5218 MATMACORP SARS-COV-2 HIGH THROUGHPUT LABORATORY CAPACITY SCALE-UP
$4,947,000Phil Kozera · Materials/ Machines Corporation/America · N02 · FY2021 · HL
Development and validation of antivirals against Flaviviruses
$4,897,582Sara Cherry · Scripps Research Institute, The · U19 · FY2022 · AI
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$4,875,891Michele K Evans · National Institute On Aging · ZIA · FY2023 · AG
Center for Multiscale Immune Systems Modeling
$4,874,388Cliburn C Chan · Duke University · U54 · FY2025 · AI
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimerâs disease in Ancestral and Admixed Populations
$4,853,251Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2025 · AG
Development of Alphavirus Replicon Vaccine Against SARS
$4,839,367Alphavax Human Vaccines, Inc. · UC1 · FY2004 · AI
Immune Tolerance Network
$4,831,165Gerald T Nepom · Benaroya Research Inst At Virginia Mason · UM1 · FY2022 · AI